Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04259814 · ClinicalTrials.gov registry record · NA
Effect of mCIMT Casting on Speech-language Outcomes in Children With Hemiparesis
A NA study of Cerebral Palsy and Hemiparesis, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT04259814: Completed NA study of Cerebral Palsy and Hemiparesis, sponsored by Shirley Ryan AbilityLab.
NCT04259814 is a NA study of Cerebral Palsy and Hemiparesis that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 3 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04259814, a NA study of Cerebral Palsy and Hemiparesis, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
Modified constraint-induced movement therapy (mCIMT) has been successfully used with children who have hemiplegia (weakness or paralysis on one side of the body.) mCIMT uses a removable cast during treatment and home exercise programs. It has been found that mCIMT can improve use, strength and coordination of a child's affected hand, and may also help improve speech and language skills. The goal of this project is to investigate whether combining mCIMT with speech therapy will enhance speech outcomes in children with cerebral palsy.
Primary Outcome
Number of trained words and phrases produced during a treatment session.
Conditions Studied
Interventions
- BEHAVIORAL Speech-language therapy (SLT)
- BEHAVIORAL Modified constraint-induced movement therapy (mCIMT)
Study Locations (1)
Illinois
- Shirley Ryan AbilityLab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2020-05-26 |
| Phase | NA |
What the finished NCT04259814 record still lists
NCT04259814 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 2 interventions - of which Speech-language therapy (SLT) is the first listed.
NCT04259814 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04259814 about?
NCT04259814 is a clinical study titled "Effect of mCIMT Casting on Speech-language Outcomes in Children With Hemiparesis". Modified constraint-induced movement therapy (mCIMT) has been successfully used with children who have hemiplegia (weakness or paralysis on one side of the body.) mCIMT uses a removable cast during treatment and home exercise programs. It has been found that mCIMT can improve use, strength and coord...
What is the current status of trial NCT04259814?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2020-01-06. Estimated completion is 2020-05-26.
What conditions does trial NCT04259814 study?
This clinical trial studies the following conditions: Cerebral Palsy, Hemiparesis, Hemiplegia, Speech and Language Disorder.
What interventions are being tested in trial NCT04259814?
The interventions under investigation include: Speech-language therapy (SLT) (BEHAVIORAL), Modified constraint-induced movement therapy (mCIMT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04259814?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04259814 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04259814's enrollment target sits among peer trials
3 92nd of 91 the lowest of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Neuromodulation of the Cortex and Spinal Cord
RECRUITING · NA
-
Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI